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Brain micro-architecture and disinhibition: a latent
phenotyping study across 33 impulsive and compulsive
behaviours
Rafa Romero-Garcia1, Roxanne W. Hook1, Jeggan Tiego 2, Richard A. I. Bethlehem 1, Ian M. Goodyer1, Peter B. Jones 1,
Ray Dolan 3,4, Jon E. Grant5, Edward T. Bullmore 1, Murat Yücel 2 and Samuel R. Chamberlain 1,6
Impulsive and compulsive symptoms are common, tend to co-occur, and collectively account for a substantive global disease
burden. Latent phenotyping offers a promising approach to elucidate common neural mechanisms conferring vulnerability to such
symptoms in the general population. We utilised the Neuroscience in Psychiatry Network (NSPN), a cohort of young people (aged
18–29 years) in the United Kingdom, who provided questionnaire data and Magnetic Resonance Imaging scans. Partial Least
Squares was used to identify brain regions in which intra-cortical myelination (measured using Magnetisation Transfer, MT) was
significantly associated with a disinhibition phenotype, derived from bi-factor modelling of 33 impulsive and compulsive problem
behaviours. The neuroimaging sample comprised 126 participants, mean 22.8 (2.7 SD) years old, being 61.1% female. Disinhibition
scores were significantly and positively associated with higher MT in the bilateral frontal and parietal lobes. 1279 genes associated
with disinhibition-related brain regions were identified, which were significantly enriched for functional biological interactions
reflecting receptor signalling pathways. This study indicates common microstructural brain abnormalities contributing to a
multitude of related, prevalent, problem behaviours characterised by disinhibition. Such a latent phenotyping approach provides
insights into common neurobiological pathways, which may help to improve disease models and treatment approaches. Now that
this latent phenotyping model has been validated in a general population sample, it can be extended into patient settings.
Neuropsychopharmacology (2021) 46:423–431; https://doi.org/10.1038/s41386-020-00848-9
INTRODUCTION
The impulsivity-compulsivity diathesis has been fruitful for
examining a range of psychiatric disorders that are commonplace
globally, as well as day-to-day behaviours. Impulsivity refers
to behaviours that are inappropriate, risky, unduly hasty, and
that lead to untoward outcomes [1]. By contrast, compulsivity
refers to repetitive, perseverative actions that are excessive and
inappropriate to a given situation [2]. For example, an individual
with attention-deficit hyperactivity disorder (ADHD) may manifest
impulsive problems such as making a statement they regret to a
colleague; or jumping a red light; whereas an individual with
obsessive-compulsive disorder (OCD) may repeatedly (i.e. com-
pulsively) check the front door is locked, for hours per occasion.
Collectively, such symptoms lead to considerable functional
impairment and burden of disease [3–6]. It was traditionally
thought that impulsivity and compulsivity were diametrically
opposed concepts, and indeed current nosological systems
often place these disorders in disparate categories. However,
impulsive and compulsive problems frequently co-occur in the
same individual, and some types of disorders, such as addictions,
may shift from being impulsive to compulsive over time [7],
suggesting that in fact both types of symptom are biologically
related.
It has been proposed that psychiatric symptoms may be driven by
common mediators (termed ‘latent phenotypes’) that cut across
conventionally discrete nosological boundaries [8, 9]. Such latent
phenotypes are expected to exist in a dimensional or continuous
fashion in the general population, confirmation of which can be
seen as a precursor to using such models in clinical settings.
Understanding of such dimensional phenotypes and their biological
substrates is highly relevant to understanding the normal range of
human behaviour, as well as prevalent mental disorders.
By collecting data regarding 33 types of impulsive and
compulsive behaviours in a population sample, it was demon-
strated that 70% of expression of these symptoms, within an
optimal statistical model, was explained by a latent phenotype
termed ‘disinhibition’ [10]. Conceptually, disinhibition—i.e. a loss
of top down control governing behaviour—has been extensively
implicated as a mechanism contributing to impulsive and
compulsive disorders (such as ADHD and OCD), viewed individu-
ally (i.e. per disorder) in prior literature [11–14]. The frontal cortices
work synergistically with other brain regions to enable top-down
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control over behaviours [15], and frontal architectural abnormal-
ities have been reported in impulsive and compulsive disorders
[16–24]. The latent phenotyping approach assumes that similar
mechanisms (such as disinhibition) operate both in normative
population samples, and in groups of people with significant
psychopathology; and that it is the extent of latent phenotype
(rather than its nature) that accounts for why some people exhibit
psychiatric symptoms meeting threshold for a diagnosis, and
others do not. The continuity of latent phenotypes has been
exemplified in other areas of mental health research, notably in
the context of psychosis [25] and general psychopathology [26].
Here, we consider common neurobiological mechanisms that may
confer vulnerability for both impulsive and compulsive symptoms,
considered dimensionally in a sample of young adults.
Myelinated fibres are extensively distributed within the cortex
[27–29], and play a key role in neural plasticity and communica-
tion between cortical regions [30]. Intra-cortical myelin content is
inversely related to neural circuit complexity: typically, higher
myelination is found in early sensorimotor cortical regions, while
lower myelination is evident in regions involved in complex
higher-level cognitive processes, notably in the frontal lobes [31].
Nevertheless, high-level associative cortices get not only thinner
during adolescence but also more myelinated, which could be
driven by a genetically patterned process of consolidation of
cortical regions that are more densely connected [32]. Previous
studies have extensively documented reduced cortical thickness
in disorders such as OCD [16] and ADHD [33]. Intra-cortical myelin
content can be readily quantified using Magnetisation Transfer
(MT) acquired using brain imaging [31], since MT exhibits strong
positive correlations with myelination in histological brain samples
[34, 35]. Frontal cortex MT was previously found to be abnormally
elevated in OCD patients compared to controls [36]. MT is
sensitive to neurodevelopmental changes in the brain [37],
including longitudinal changes associated with impulsive traits
and OC symptoms [38], and is a promising measure of brain
architecture that can be related to dimensional phenotypes [39].
Given this explanatory power of the latent disinhibition
phenotype, coupled with individual differences in myelin-related
brain growth during early adulthood [40], understanding the neural
mechanisms underpinning this novel latent phenotype is an
important next step. Therefore, the primary aim of the current
study was to identify relationships between intra-cortical myelina-
tion (quantified using MT) and the expression of a latent phenotype
of disinhibition [10]; i.e. disinhibition-related myelination. Our
premise was that disinhibition arises from alterations in frontal
brain architecture, manifesting as increased intra-cortical white
matter (MT) and concomitant reductions in cortical thickness. In
view of the centrality of certain neurochemical systems in under-
standing impulsivity and compulsivity [41, 42], along with recent
methodological developments [40, 43], the secondary aim of this
study was to inferentially ascertain genes co-localised with
disinhibition-related cortical regions, by cross-referencing against a
public-domain brain atlas [44]. We hypothesised (i) that disinhibition
would be associated with elevated MT (and concomitant reductions
in grey matter cortical thickness), in frontal and other cortical
regions; and (ii) that genes significantly associated with disinhibition-
related regions would be identified, which would be inferentially
enriched for functional interactions involving receptor signalling
pathways implicated in impulsivity/compulsivity.
MATERIALS AND METHODS
Study design
An overview of the study design is provided in Fig. 1. Participants
were recruited from a cohort of young people being followed over
time to evaluate human development (the Neuroscience in
Psychiatry Network, NSPN) [45]. The original NSPN cohort (primary
cohort) comprised participants aged 14–25 years at enrolment,
who were assessed by completion of psychopathology ques-
tionnaires. Subjects were recruited in five contiguous age-related
strata, each balanced for sex and ethnicity. Exclusion criteria were
a current or past history of clinical treatment for a psychiatric
disorder, drug or alcohol dependence, neurological disorder
including epilepsy, head injury causing loss of consciousness, or
learning disability.
NSPN constitutes what can be considered a normative cohort, but
not exclusively ‘healthy controls’. This makes the cohort extremely
useful for exploring candidate latent phenotype markers, since
problem behaviours will occur along continua, from no problems to
many problems. A secondary cohort of these participants addition-
ally completed a later in-unit assessment comprising magnetic
resonance imaging (MRI). The secondary cohort was demographi-
cally balanced, and was sub-sampled from the primary cohort
[43, 45]. Contraindication to MRI was exclusionary for the secondary
cohort. We subsequently collected information regarding a com-
prehensive range of impulsive and compulsive problems by re-
contacting the primary cohort (see Fig. 1), as described in more
detail below.
Ethics
All participants provided written informed consent and this research
was approved by Research Ethics Committee (East of England—
Cambridge East Research Ethics Committee).
Recruitment of original 
NSPN Cohort (N=2400, 
Primary Cohort)
Representave subset 
undertakes MRI (N=318, 
Secondary Cohort)
Primary cohort re-contacted to 
collect impulsive and compulsive 
measures (N=2400)
Disinhibion












Extracted disinhibion scores 
Opmal model idenfied based on fit 




































Step A: 1st PLS -
Idenfy disinhibion-
related regions






Enrichment analysis Protein-Protein Interacons network 
Cell type 
affiliaon
Fig. 1 Overview of study design. Disinhibition scores for each
subject were extracted using a previously validated optimal bi-factor
model. We first (Part A) used Partial Least Squares (PLS) regression to
map intra-cortical myelination to those disinhibition scores. We then
(Part B) used PLS to identify genes inferentially over-expressed in
those disinhibition-related brain regions.
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Bi-factor modelling of impulsive and compulsive symptoms
(primary cohort)
Information on impulsive and compulsive symptoms was col-
lected from 654 NSPN participants, who completed the Impulsive-
Compulsive Behaviours Checklist (ICBC) [10]. This was achieved by
contacting all individuals from the primary cohort via email, and
inviting them to complete a follow-up questionnaire comprising
more detailed information about impulsive and compulsive
problems. This subset of the NSPN cohort who provided ICBC
data were representative of the original cohort in terms of age at
enrolment, gender, and ethnicity (Table S1). The ICBC [46]
quantified 33 impulsive and compulsive symptoms; for example,
it includes impulse control problems (gambling, substance use,
aggression, etc.) and compulsive problems (e.g. washing, check-
ing, making lists, counting, etc.) (Table S2). In prior analysis of
structural models capable of explaining ICBC responses, the
optimal model (according to fit parameters) was the bi-factor
model shown in Fig. 1. The bi-factor model has superior model fit
to the approach of using summary scores, across the full range of
fit parameters (Comparative Fit Index, CFI; Root Mean Square Error
of Approximation, RMSEA; Weighted Room Mean Square Residual,
WRMR; and chi-square test) [10]. As such, the bi-factor approach is
clinically preferred, rather than using (for example) the numerical
sum of scores from the instrument, because the latter results in
marked loss of information content. This bi-factor model yields the
latent phenotype of disinhibition, which accounts for ~70% of
explained variance in the expression of these 33 ICBC symptoms
[10]. This disinhibition factor has some conceptual similarities with
the “p factor” [47], but differs in that it applies specifically to
impulsive and compulsive problems, rather than to other forms of
psychopathology. This disinhibition model is also supported by
complementary lines of evidence using other instruments,
in normative and mixed clinical and non-clinical samples,
including participants diagnosed with Gambling Disorder and
OCD (i.e. archetypal impulsive and compulsive disorders) [48, 49].
To contextualise the levels of archetypal forms of impulsivity and
compulsivity in the sample, participants also completed self-report
questionnaires for ADHD [Adult ADHD Self-Report Screening Scale
[50]], and OCD [Padua Obsessive-Compulsive Inventory (Washing-
ton State Revision) [51]]. In particular, it was intended to correlate
latent disinhibition scores against these archetypal impulsive and
compulsive symptoms, as measured using independent instru-
ments, to support the validity of the model. Total scores from the
Adult ADHD Self-Report Screening Scale and Padua Inventory
were used for this purpose; we additionally examined sum of
scores for impulsive items and inattentive items from the ADHD
Scale separately, the expectation being that disinhibition would
relate to impulsive items but not inattentive items.
Normalised and standardised disinhibition factor score esti-
mates (hereafter referred to as ‘disinhibition scores’) were
calculated using the regression method based on the modelling
of N= 654 participants for whom complete ICBC data were
available. We confirmed that the distribution of disinhibition
scores for the imaging sample did not differ from those of non-
imaging sample (imaging, mean [SD], 0.07 [0.84]; non-imaging,
0.06 [0.81]; F= 0.0297, p= 0.863).
For the 126 participants for whom MRI data were also available,
we explored the disinhibition-related relationships between cortical
MT measurements in 308 cortical areas, and the disinhibition factor
score estimates, as described below. MRI data were not collected
from everyone in the original NSPN study but rather from a random
representative subset.
MRI measurement of intra-cortical magnetisation transfer
(secondary cohort)
Magnetic resonance imaging was undertaken using identical 3T
MRI systems (Magnetom TIM Trio; VB17 software version;
Siemens Healthcare) operating with the standard 32-channel
radio-frequency (RF) receive head coil and RF body coil for
transmission and located at the Wolfson Brain Imaging Centre,
University of Cambridge; the Medical Research Council (MRC)
Cognition & Brain Sciences Unit, University of Cambridge; or the
Wellcome Trust Functional Imaging Laboratory (FIL) at University
College London. Multi-parametric mapping (MPM) sequences
were used to collect data on several microstructural parameters
in a single scan, with satisfactory between-site reliability of
measurement across all sites in a prior pilot study, e.g., the
percentage (standard deviation) of between-site coefficient of
variation for Magnetisation Transfer (MT) was 7.8 ± 0.8, 7.6 ± 2.7,
6.1 ± 0.6 and 7.4 ± 2.8 for grey matter, caudate nucleus, white
matter and corpus callosum, respectively [52]. MPM comprises
3 multi-echo fast low angle shot (FLASH) scans with variable
excitation flip angles. Multiple gradient echoes were acquired with
alternating readout polarity at six equidistant echo times (TE)
between 2.2 and 14.7 ms for the T1 weighted and MT weighted
acquisitions and at 8 equidistant MT was quantified by appro-
priate choice of repetition time (TR) and flip angle (TR= 23.7 ms,
α= 6°). Other acquisition parameters were: 1 mm3 voxel resolution,
176 sagittal slices and field of view (FOV)= 256 × 240mm.
Pre-processing of MRI data was undertaken using Freesurfer
pipelines [53], version 5.3.0. In brief, each image was subjected to
skull stripping, segmentation, and reconstruction of the pial
surface [54–56]. The Desikan-Killany atlas of 68 regions imple-
mented in Freesurfer was subdivided into 308 contiguous parcels
of approximately equal area of 500 mm2 using a subparcellation
algorithm described in [57]. Increasing the resolution of the atlas
allow us to define homogeneous parcels where regions
represent the same proportion of the cortex and have similar
SNR (i.e. average regional MT values are computed for each
region across approximately the same number of voxels). The
subdivided (308) parcellation was transformed from standard
fsaverage space into the native space of each individual using
surface-based corregistration to minimise geometric distortions
and age-related biases [40, 57].
At each regional node, magnetisation transfer (MT) was
estimated intra-cortically at 70% cortical depth, where pial surface
was 0% depth and grey-white boundary was 100% depth [32]. We
also extracted cortical thickness at each regional node, according
to standard methodology [32].
Our overall imaging analytic approach used two distinct steps.
First (Part A), we tested the relationship between intra-cortical
myelination (MT) and disinhibition factor scores. Second (Part B),
we used a gene expression matrix to identify genes overexpressed
in the disinhibition-related brain regions identified from Part A
(see Fig. 1 for illustration).
Part A: analysis of relationships between cortical MT and
disinhibition scores
We used the statistical technique of Partial Least Squares
Regression (hereafter referred to as PLS) to identify relationships
between MT and disinhibition. PLS is a multivariate statistical
technique for modelling relationships between predictor and
response variables, by fitting one or more components [58–60].
Unlike conventional statistical approaches (such as standard
regression), PLS is suitable for use when variables are likely to be
inter-correlated, and non-normal; and in datasets with relatively
large numbers of variables relative to the sample size [61].
The first PLS analysis used many predictors (308 brain regions)
to identify a combination of brain regions related to one outcome
(126 disinhibition scores). The predictor variables comprised a
matrix of 126 rows (participants) by 308 columns (intra-cortical MT
measurements in each brain parcel). The response variable was a
vector of length 126 (disinhibition scores). We fitted PLS models
using leave-one-out (LOO) cross-validation (non-linear iterative
partial least squares, NIPALS algorithm), and the optimal model
was identified based on minimising predictive residual sum of the
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squares (PRESS). LOO cross-validation is preferred in situations
involving relatively large numbers of variables [62]. From the initial
model, measures with a Variable Importance Parameter (VIP) < 0.8
were excluded per standard PLS recommendations [63]. We then
used bootstrapping [resampling with replacement [64] with 2500
iterations] to confirm whether the 95% confidence intervals for
the amount of variance explained in the predictive and response
variables, for this model, was significantly higher than those
accounted for by a randomly permuted model. Individual
predictive variables significantly contributing to the model (i.e.
cortical MT in the parcelled brain regions explaining variance
in disinhibition scores) were identified on the basis of 95%
confidence intervals of the standardised model coefficients for
the given predictor variable, again obtained using bootstrap
(2500 iterations), did not cross the null line (i.e. zero). To identify
normative psychological processes linked to the model coefficient
of disinhibition-related brain regions, we used the Neurosynth tool
(http://neurosynth.org) [65], which comprises a large pooled
database of functional neuroimaging studies.
Correlations were undertaken between PLS scores and total
scores from: the Adult ADHD Self-Report Screening Scale [50], and
the Padua Obsessive-Compulsive Inventory (Washington State
Revision) [66]. These two instruments measured archetypal
impulsive and compulsive symptoms respectively; and were not
used in the construction of the PLS model, nor in the calculation of
disinhibition scores. Hence these correlations were undertaken to
affirm that the identified brain regions were also related to these
archetypal symptom types, as would be expected for a disinhibi-
tion phenotype. We checked that the findings were not
confounded by alcohol use by correlating against total scores
from the well-validated FAST alcohol use disorder tool [67].
Part B: inferential mapping of brain genes whose expression
related to disinhibition-relevant brain regions
To identify genes whose expression was inferentially correlated
with the disinhibition-related brain regions, we used a second,
separate PLS model. This second PLS analysis used many
predictors (maps of brain gene expression) to identify genes
inferentially over-expressed in disinhibition-related brain regions.
The predictor variables constituted a gene expression matrix of
308 rows (i.e. 308 brain parcels) by 20647 columns (i.e. 20647
genes). The response variable constituted a vector of 308 values,
being the matrix of disinhibition-related MT obtained in Part A.
The micro-array gene expressions were obtained by utilising the
Allen Human Brain Atlas database, which is a dataset from six
adult donors whose brain expressions in different regions were
quantified post mortem (three Caucasian, two African-American
and one Hispanic; five males, one female; aged 57, 55, 49, 39, 31
and 24 years; www.brain-map.org) [44]. While this atlas comprises
data from few subjects, it currently constitutes the gold standard
in the field for cross-referencing against brain gene expression,
until future larger studies are conduced across a broader set of
subjects. Full details of the methodology for obtaining these gene
expressions, and mapping them to cortical parcels are provided in
[43]. The first PLS component was extracted, representing the
linear combination of the weighted gene expression scores that
had a cortical expression map that was most strongly associated
with the disinhibition-related brain region map. Permutation
testing based on 10,000 spherical rotations or “ spins” of the
spatially correlated disinhibition-related myelination map (Pspin)
was used to test the null hypothesis that PLS explained no more
covariance between disinhibition-related myelination and whole-
genome expression than expected by chance [68].
Bootstrapping was used to estimate the variability of each
gene’s weight on PLS and we tested the null hypothesis of zero
weight for each gene with false discovery rate (FDR) of 5%. The
STRING tool (https://string-db.org) [69] was then used to test for
the presence of significant functional enrichment (i.e. gene-gene
interactions) of the significant PLS genes against Gene Ontology
Biological Processes, with Benjamini–Hochberg FDR correction
(q < 0.05). We assigned a cellular affiliation score to each gene in
the PLS gene list according to prior criteria for 4 cell types—
neuron, astrocyte, microglia, or oligodendroglia [70]. We used a
permutation test procedure that randomly reassigned cellular
affiliation scores across genes to test the null hypothesis that
genes correlated with disinhibition-related myelination have
random cell type affiliations.
RESULTS
The demographic characteristics of the 126 subjects in the
imaging analyses are provided in Table 1. The average (Standard
Deviation) number of problematic behaviours endorsed per
subject to at least a moderate degree was 2.2 (3.6), with a range
of 0–17.
Relationship between cortical MT and disinhibition scores
PLS revealed an optimal one-factor model, explaining 48% of MT
variance in the identified brain regions, and 9.6% of variance in
the disinhibition scores. Age, education, and gender were not
significant contributors when added to this model, and nor was
study site (all VIP < 0.8). The amount of disinhibition variance
explained by the model differed significantly from that of the null
model (Bootstrap p < 0.05). Disinhibition-related myelination
cortical regions are shown in Fig. 2. Of 141 cortical parcels in
the model, 61 were significant (bootstrap p < 0.05). Significant
regions in both hemispheres comprised: frontal cortex (inferior,
middle, superior, posterior cingulate, paracentral gyrus), and
parietal cortex (superior, postcentral gyrus, supramarginal gyrus,
precuneus). Additionally, left middle temporal cortex, and left pre-
central gyrus, were significant. Higher MT (indicative of lower
intra-cortical myelination) was associated with higher disinhibition
scores in all the identified significant regions (see Table S3 for the
full list of brain parcels and their model coefficients). As expected,
disinhibition was also associated with concomitant reductions of
cortical thickness in the implicated neural regions (Fig. 2).
PLS brain scores correlated significantly with ADHD symptoms
(ADHD Self-Report Screening Scale, rho= 0.294, p= 0.001) and
with OCD symptoms (Padua Obsessive-Compulsive Inventory,
rho= 0.285, p= 0.001) (Fig. S1), these rating scales being separate
from the instrument used to construct the original disinhibition
scores. Additionally, the correlation was specifically significant for
the sum of the impulsive items from the ADHD Self-Report
Screening Scale (items 5 & 6, p= 0.0003) but not for the sum of
the inattentive items (items 1–4, p= 0.4579). Brain scores were
unrelated to alcohol use, as indexed by total scores on the FAST
Table 1. Sample characteristics.
Mean (Standard Deviation)
[range] or N [%] N= 126
Age, years 22.8 (2.7) [18, 29]
Gender, Female 77 [61.1%]
Ethnic groupa
White Caucasian 101 [83.5%]
Mixed/Multiple ethnicity 12 [10.0%]
Asian/Asian British 5 [4.1%]
Other 3 [2.5%]




aFive subjects did not disclose their ethnic group.
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(p= 0.182). Distributions of disinhibition scores, and total scores
on the ADHD and OCD inventories, are shown in Fig. S2.
In terms of the disinhibition model’s transcriptomic signature,
PLS identified an optimal one-factor model that explained 11.3%
of variation in brain gene expression and 30.9% of variation
in disinhibition-related myelination. The amount of variance
explained by the model differed significantly from the null models
based on spun parcellation that controlled for regional contiguity
and hemispheric symmetry (Pspin= 0.0014). There were 1279
genes significantly weighted on the PLS component (bootstrap,
p < 0.05, FDR corrected). PLS analyses were repeated using both
disinhibition-related myelination and disinhibition-related cortical
thickness as response variables in the same model. However,
explained variance of the model was reduced to 15.0% (Pspin=
0.022) and the resulting gene weights were extremely similar to
the PLS disinhibition-related myelination standalone model (R2=
0.95; Fig. S3). For those reasons, the following analyses were
restricted to the disinhibition-related myelination model only.
Genes weights derived from the disinhibition-related myelination
model were well differentiated from gene weights derived from a
schizotypy-related model [39] established in a recent study, with
low overlap (R2= 0.02; Fig. S3).
Significantly positively weighted genes on the PLS component
(Top PLS) were enriched for astrocyte affiliation (permutation
test, P < 10−4) whereas significantly negatively weighted genes
(Bottom PLS) were enriched for microglia and oligodendrocyte
affiliation (permutation test, P < 10−4). The top expressed 500
genes in this model are visualised in Fig. 3 using the STRING tool
(see Table S4 for full list of genes). The protein-protein interactions
that were enriched in the network are summarised in Table 2.
It can be seen that the network was significantly enriched for
protein-protein interactions relating to a variety of processes
including neurochemical transmission (especially G protein-
coupled receptor signalling pathways), cellular and biological
adhesion, and high-level systems processes.
DISCUSSION
This study identified micro-structural brain changes associated
with an innovative latent phenotype of disinhibition, contributing
to 33 impulsive and compulsive problems, in young adults. In
keeping with our hypothesis, we found that the latent disinhibi-
tion phenotype was associated with higher Magnetisation Transfer
(MT), indicative of higher intra-cortical myelination, in bilateral
frontal and parietal cortices. There were concomitant reductions of
cortical thickness in these regions, as predicted. These results are
in accordance with the premise that disinhibition may arise from
micro-architectural brain changes impeding the ability of the
cortex to exert sufficient control over impulsive and compulsive
tendencies. By cross-referencing against a gene expression human
brain atlas, we also inferred a transcriptomic profile related to the
disinhibition-myelination association; i.e. a network of interacting
genes that were co-localised with the disinhibition-related
regions. The set of genes differentiated well from those previously
implicated in a distinct latent phenotype of schizotypy [39]. These
functionally enriched gene-gene interactions were primarily
involved in neurochemical transmission (specifically, neuropeptide
and G-coupled receptors, and transmembrane signalling).
Fig. 2 Results of PLS modelling linking Magnetisation Transfer (MT) to the latent disinhibition phenotype. Top left: Glass brain showing
disinhibition-related regions in which intra-cortical myelination was significantly associated with disinhibition (dark brown: significant by
bootstrap; light brown: variable importance parameter >0.8 but did not withstand bootstrap). Top-right: word cloud showing normative
psychological processes linked, in functional imaging literature, to the disinhibition-related brain regions (http://neurosynth.org) [65]. It can be
seen that many ontological terms related to motor planning and execution. Bottom left: plot of PLS Scores against disinhibition scores.
Bottom right: plot of cortical thickness in those same regions, against disinhibition scores.
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This latent phenotyping approach [8], highlighted as being
valuable in the context of impulsivity-compulsivity [9], has
received little application in this field to date. The overwhelming
majority of studies examining neural underpinnings of impulsivity-
compulsivity have used a case-control design. Current disease
models of OCD and ADHD have separately implicated dysregula-
tion of cortical regions, including the frontal lobes, responsible for
the suppression of inappropriate behaviours [12, 41, 71–73]. These
case-control approaches are extremely valuable. However, the
manifestation of psychiatric disorders can be seen as stemming
from extremely complex interactions between genetic and
environmental factors, and so may be relatively “distal” to the
underlying biological mechanisms explaining vulnerability [8].
Intermediate biologically-grounded phenotypes in the broader
population may be more tractably linked to particular brain
structural changes and expression of relevant genes. As rigorously
demonstrated here using such a latent phenotyping approach,
a broad range of impulsive and compulsive problems was
associated with common micro-structural cortical abnormalities,
namely elevated intra-cortical Magnetisation Transfer (MT) (Fig. 2).
MT reflects the ratio of lipid to watery tissue in a particular brain
region [74], and constitutes a developmental marker of myelina-
tion [75], being strongly correlated with actual myelination
according to histology [34, 35]. There were concomitant reduc-
tions of cortical thickness. Collectively, these results are in keeping
with our hypothesis that changes in cortical structure underpin
disinhibition, by interfering with the ability of the cortex to
sufficiently regulate urges and habits.
Due to the relatively recent emergence of imaging pipelines
suitable for quantifying intra-cortical MT, there is a paucity of
studies against which to compare the current results, highlighting
the novelty of the study. Of note, the frontal regions associated
with disinhibition we observed herein overlap with frontal regions
previously found to have elevated MT in OCD patients versus
controls [36]. Also of note, we found that disinhibition was
associated with concomitant reductions of cortical thickness in the
Fig. 3 Protein-protein interaction network for top 500 genes whose expression mapped onto the disinhibition phenotype (all genes
significant at FDR p < 0.001 in the PLS model). Nodes represent genes whose expression was positively associated with disinhibition-related
Magnetisation Transfer (MT). Edges (i.e. lines) are known protein-protein interactions, and their weights are proportionate to the STRING
confidence score. Only connected notes with high confidence (>0.7) are shown.
Brain micro-architecture and disinhibition: a latent phenotyping study. . .
R Romero-Garcia et al.
428
Neuropsychopharmacology (2021) 46:423 – 431
implicated neural regions. Previous studies have extensively
documented reduced cortical thickness in disorders such as
OCD [16] and ADHD [33]. The frontal lobes play a classic role in the
suppression of both impulsive and compulsive response tenden-
cies, according to neurobiological models of such disorders as
ADHD [13] and OCD [12, 73, 76]. However, in addition to frontal
regions, and extending beyond our initial hypothesis, higher MT in
other brain regions (mainly parietal) was also significantly related
to disinhibition. Tiers of evidence using other imaging techniques
implicate many of these regions in impulsive and compulsive
disorders, even though the traditional focus has been on the role
of the frontal lobes [16, 60, 77–80].
By using data from the Allen Brain Human Atlas, we were able
to infer genes, and enriched gene-gene interactions, significantly
co-localised with the disinhibition-related brain map (Fig. 3 and
Table 2). The set of genes was significantly enriched, in terms of
gene-gene interactions, for biological processes involved in
receptor signalling (peptide and G-Protein related).
Though this is the first study to explore brain substrates of
disinhibition viewed across a comprehensive range of impulsive
and compulsive problems, several limitations should be
considered. Firstly, the current research was undertaken in a
cohort recruited to be epidemiologically representative of the
background population. In keeping with this, the mean scores
on conventional impulsivity and compulsivity self-report scales
were similar to those found in previous normative cohorts
[51, 81, 82]. Though such a cohort is ideal for work on
dimensional psychopathology, more extreme expression of
disinhibition is to be expected in patient populations.
We did not examine neural and genetic associations with the
residual impulsivity and residual compulsivity factors, since the vast
majority of variance in impulsive-compulsive behaviours was
explained by the disinhibition factor. By taking this approach, we
do not mean to suggest that there are not distinct mechanisms also
differentially contributing to impulsive and compulsive disorders
[49]. But rather, we highlight the importance of considering
common neural mechanisms related to disinhibition in future work,
since this appears to be a major contributor to many forms of
impulsive and compulsive behavioural manifestations, and is seldom
considered in impulsivity/compulsivity research. It remains to be
determined whether these findings would generalise to different
cohorts, such as older participants (who may have relatively
lower impulsivity). The identification of genes co-localised with
disinhibition-related brain regions was by necessity an inferential
analysis of gene expression in adults using the Allan Brain Atlas,
since it is not possible to measure protein expression in vivo. Age
and gender did not significantly explain the occurrence of
disinhibition in statistical modelling. However, because Allan Brain
Atlas donors were not matched to the current dataset in terms of
demographic characteristics, some caution is needed when inter-
preting gene findings. The expression of particular forms of
impulsive of compulsive problems may of course relate to these
variables (e.g. antisocial tendencies are generally higher in men),
indeed as previously demonstrated for residual factors using this bi-
factor model [10]. Our results indicate that the common factor
contributing to the full range of impulsive and compulsive problems
was not significantly related to age or gender. Neuroimaging in the
NSPN cohort was not conducted in all subjects, but rather on a
representative subsample, as is common in cohort studies due to
the relatively high cost of conducting brain scans. However, the
sample size was ample to determine brain relationships, including
with rigorous cross-validation procedures. Moreover, while larger
imaging cohorts exist, they do not generally measure impulsive and
compulsive problems sufficiently in order to quantify related
dimensional phenotypes. For example, they might typically measure
ADHD and OCD in binary form (presence or absence), but this is
insufficient information from which to construct a valid disinhibition
model. Lastly, the latent disinhibition phenotype correlated
with impulsive and compulsive symptoms viewed dimensionally,
including archetypal impulsive (ADHD) and compulsive (OCD)
symptoms measured using standard rating scales not used to
calculate the original disinhibition scores. Starting with a normative
sample constitutes a vital precursor to work in patient groups, in
keeping with the widely advocated Research Domain Criteria
approach [8], with a view towards confirmation of truly trans-
diagnostic phenotypes.
In summary, this study identified common architectural brain
changes underlying a latent phenotype of impulsive and
compulsive problems. The findings are directly relevant to
understanding common biological processes conferring vulner-
ability to a range of problematic behaviours, as well as conditions
such as ADHD and OCD. Future work could apply this phenotyp-
ing strategy in patient populations and evaluate the effects of
existing and new treatments on this marker. We hypothesise that
this latent dimensional phenotype will present in more extreme
forms in such clinical groups. The latent phenotype focus is
potentially valuable in order to improve disease models, but also
as a means of developing treatments (including early interven-
tions) capable of subverting those common aetiological pathways
contributing to the emergence of a range of impulsive and
compulsive problems.
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